reMYND NV

Where the EU money came from

Funding by EU programme. Amounts are reMYND NV's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Each links to the official record.

• PANAPartner

  PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.

  Horizon 2020 · 2016–2021 · Project on CORDIS ↗

  €483ktheir share
• AGEDBRAINSYSBIOPartner

  SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €259ktheir share
• NPLASTPartner

  NPlast - A neuroscience school that aims to preserve and restore neuroplasticity in brain disorders

  FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

  €242ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
• Katholieke Universiteit LeuvenBelgium · 1 shared project
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
• Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
• Universiteit UtrechtNetherlands · 1 shared project
• The University of EdinburghUnited Kingdom · 1 shared project
• Tel Aviv UniversityIsrael · 1 shared project
• European Molecular Biology LaboratoryGermany · 1 shared project
• Stichting VuNetherlands · 1 shared project
• Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
• Universite de GeneveSwitzerland · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Vib vzwBelgium · 1 shared project
• Ita-Suomen YliopistoFinland · 1 shared project
• Universidad de Santiago de CompostelaSpain · 1 shared project
• Heinrich-Heine-Universitaet DuesseldorfGermany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• alzheimer
• drug discovery
• genomes
• immunotherapy
• neurobiology
• nuclear medicine
• pathology
• pharmaceutical drugs
• proteomics
• stem cells